Echocardiography: Clinical Trials

718 trials of Echocardiography, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

192 recruiting, 188 completed, 152 unknown, 94 active not recruiting. 140 Phase 2, 115 Phase 1, 105 Not applicable, 34 Phase 3, 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2140Recruiting 60, Active not recruiting 48, Completed 13, Not yet recruiting 8, Terminated 6, Withdrawn 3, Suspended 2
Phase 1115Recruiting 55, Active not recruiting 26, Completed 9, Suspended 7, Withdrawn 7, Terminated 6, Not yet recruiting 5
Not applicable105Completed 52, Unknown 22, Recruiting 15, Not yet recruiting 5, Active not recruiting 4, Terminated 4, Withdrawn 2, Suspended 1
Phase 334Active not recruiting 14, Recruiting 12, Completed 5, Not yet recruiting 2, Terminated 1
Phase 45Completed 4, Unknown 1
Early Phase 12Recruiting 1, Withdrawn 1

Follow Echocardiography: new trials by email Literature Review of Echocardiography trials Research Report on Echocardiography

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomography - Recurrent Ganglioneuroblastoma, Recurrent Neuroblastoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)762027-06-252026-10-22
Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma
Biospecimen Collection, Diagnostic Imaging Testing, Echocardiography Test - Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)312027-06-012026-10-22
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma
Phase 1Not yet recruitingCity of Hope Medical Center162027-04-172026-08-11
Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female Runners
Echocardiography, Arterial ultrasound, Blood sampling - Healthy Volunteer
Not applicableNot yet recruitingFrench Cardiology Society1202027-03-202026-10-09
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
Biopsy Procedure, Biospecimen Collection, Breast Conservation Treatment - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma
Phase 3RecruitingSWOG Cancer Research Network5622027-03-092026-10-13
Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors
Aldesleukin, Biospecimen Collection, Chest Radiography - Locally Advanced Gastrointestinal Stromal Tumor, Metastatic Gastrointestinal Stromal Tumor
Phase 2Not yet recruitingJoal Beane592027-02-152026-10-13
Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma
Biospecimen Collection, Bone Scan, Computed Tomography - Non-Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 3Not yet recruitingNational Cancer Institute (NCI)4002027-02-102026-07-08
Testing the Investigational Medication Combination of Azacitidine, Venetoclax, and Quizartinib Compared to the Usual Treatment of Cytarabine, Daunorubicin, and Quizartinib for Patients With FLT3-ITD Mutant Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Azacitidine, Biospecimen Collection, Bone Marrow Aspiration - Acute Myeloid Leukemia
Phase 2Not yet recruitingNational Cancer Institute (NCI)1222027-01-152026-10-07
Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Biopsy - Acute Myeloid Leukemia
Phase 2Not yet recruitingNational Cancer Institute (NCI)2442027-01-152026-10-20
Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)
Azacitidine, Bone Marrow Aspiration and Biopsy, Cytarabine - Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Phase 2Not yet recruitingNational Cancer Institute (NCI)1842027-01-042026-10-01
Radiological Markers for PDA Management in Preterm Infants
Organ doppler, Echocardiography - Patent Ductus Arteriosus in Preterm Infants
Not applicableNot yet recruitingAssiut University882027-01-012026-09-10
Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Asciminib, Biospecimen Collection, Bone Marrow Aspiration - B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Phase 1RecruitingCity of Hope Medical Center302026-12-172026-10-19
BSB-2002 After Cyclophosphamide and Fludarabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Phase 1Not yet recruitingCity of Hope Medical Center192026-12-142026-05-13
Testing Safe Doses of Anti-Cancer Medicines, 5-Flurouracil (5-FU) and Tretinoin (ATRA), Added to the Usual Cancer Treatment of Ependymoma
Biospecimen Collection, Echocardiography Test, Fluorouracil - Childhood Posterior Fossa Ependymoma
Phase 1 / Phase 2Not yet recruitingChildren's Oncology Group702026-12-112026-09-30
Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype
Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography - Richter Syndrome, Diffuse Large B-Cell Lymphoma
Phase 2RecruitingRoswell Park Cancer Institute322026-11-152026-10-02
Autologous CAR T Cells Targeting GPC3 (RPCAR01) for the Treatment of Advanced or Metastatic GPC3 Expressing Hepatocellular Carcinoma
Anti-GPC3-CAR Autologous T Lymphocytes, Biospecimen Collection, Computed Tomography - Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma
Phase 1SuspendedRoswell Park Cancer Institute242026-11-152026-09-15
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
Biospecimen Collection, Bone Marrow Biopsy, Computed Tomography - Acute Myeloid Leukemia With Complex Karyotype, Myelodysplastic Chronic Myelomonocytic Leukemia
Phase 2RecruitingCity of Hope Medical Center352026-11-052026-10-08
Biomarker Testing to Predict Radiation-Related Heart Disease in Lung Cancer Patients
Serum Pro-N-Cadherin Biomarker Assessment, Echocardiogram - Non-Small Cell Lung Cancer, Radiation-Induced Cardiac Disease
Not applicableNot yet recruitingDuke University502026-11-012026-10-09
Right Heart Injury Monitoring on ECMO
Transthoracic echocardiogram, High sensitivity troponin, N-terminal pro-B-type natriuretic peptide - Acute Respiratory Distress Syndrome (ARDS), Acute Respiratory Failure (ARF)
Not yet recruitingPapworth Hospital NHS Foundation Trust302026-11-012026-10-19
IL-18 Armored STEAP1 CAR T Cells for the Treatment of Metastatic Castration Resistant Prostate Cancer
FH-STEAP1 IL-18 CAR T cells, Antiandrogen Therapy, Biospecimen Collection - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 1Not yet recruitingFred Hutchinson Cancer Center202026-10-312026-09-04

Showing 20 of 718. Sign in to see all of them.

Conditions studied

Heart Failure (56)  ·  Leukemia, Myeloid, Acute (42)  ·  Myelodysplastic Syndromes (21)  ·  Multiple Myeloma (20)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (20)  ·  Heart Diseases (19)  ·  Atrial Fibrillation (18)  ·  Cardiotoxicity (18)  ·  Hypertension, Pulmonary (18)  ·  Aortic Valve Stenosis (16)  ·  Lung Neoplasms (16)  ·  Lymphoma (16)  ·  Ventricular Dysfunction, Left (16)  ·  Breast Neoplasms (15)  ·  Burkitt Lymphoma (15)

Sponsors

National Cancer Institute (NCI) (119)  ·  Assiut University (46)  ·  City of Hope Medical Center (27)  ·  Mayo Clinic (24)  ·  Fred Hutchinson Cancer Center (20)  ·  Children's Oncology Group (13)  ·  Roswell Park Cancer Institute (9)  ·  OHSU Knight Cancer Institute (8)  ·  Sohag University (8)  ·  Universitair Ziekenhuis Brussel (6)  ·  Central Hospital, Nancy, France (5)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (5)  ·  Centre Hospitalier Universitaire de Nīmes (4)  ·  Centre Hospitalier Universitaire, Amiens (4)  ·  Duke University (4)

Countries

United States (300)  ·  France (54)  ·  Canada (41)  ·  Egypt (35)  ·  United Kingdom (32)  ·  Puerto Rico (26)  ·  China (22)  ·  Italy (20)  ·  Germany (17)  ·  Belgium (16)  ·  Australia (15)  ·  Turkey (Türkiye) (14)  ·  South Korea (13)  ·  Denmark (12)  ·  Spain (12)

Top investigators

Ibrahim Aldoss (6)  ·  Amandeep Salhotra (4)  ·  Joyce F Liu (4)  ·  A P Chen (3)  ·  Curtis A Lachowiez (3)  ·  Gerry P McCann, MD (3)  ·  Stephen E Spurgeon (3)  ·  Amer M Zeidan (2)  ·  Andrea B Apolo (2)  ·  Anthony Yu, MD (2)  ·  Barry Borlaug, MD (2)  ·  Behnam Badie (2)  ·  Bonnie Ky, MD (2)  ·  Christopher J Melani, M.D. (2)  ·  Funda Meric-Bernstam (2)

Results publications

PMID 35031545, PMID 37185961, PMID 37480391, PMID 41911908, PMID 10630638, PMID 11093410, PMID 11168819, PMID 11410086, PMID 11779731, PMID 12065368, PMID 12386506, PMID 12401529, PMID 12505587, PMID 12642369, PMID 12668504, PMID 12693356, PMID 12818977, PMID 12860883, PMID 138494, PMID 1401629, PMID 14662525, PMID 15090944, PMID 15175438, PMID 15182113, PMID 15277423, PMID 15301332, PMID 15557363, PMID 15920175, PMID 16311456, PMID 16461844, PMID 16714767, PMID 16720953, PMID 16905554, PMID 17390329, PMID 17426660, PMID 17515464, PMID 17572266, PMID 18071034, PMID 18381378, PMID 18467896, PMID 18650200, PMID 18824760, PMID 19366774, PMID 19376734, PMID 19442889, PMID 19593546, PMID 20117435, PMID 20530615, PMID 20609967, PMID 20625114

NIH funding

P30CA033572 (27), U10CA180820 (24), U10CA180886 (19), U10CA180888 (12), U10CA180821 (11), U10CA180868 (9), UM1CA186689 (9), UM1CA186709 (9), UM1CA186688 (8), UM1CA186717 (6), UM1CA228823 (6), UM1CA186644 (5), UM1CA186704 (5), ZIABC011078 (5), UM1CA186691 (4)